We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$205M
AUM Growth
+$35.6M
Cap. Flow
-$35.2M
Cap. Flow %
-17.19%
Top 10 Hldgs %
38.54%
Holding
227
New
51
Increased
39
Reduced
41
Closed
39

Top Buys

Rank Stock Value
1
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$2.06M
2
APPS icon
Digital Turbine
APPS
+$1.87M
3
MRK icon
Merck
MRK
+$1.39M
4
PFE icon
Pfizer
PFE
+$1.11M
5
BWEN icon
Broadwind
BWEN
+$1.05M

Top Sells

Rank Stock Value
1
DZSI
DZS Inc. Common Stock
DZSI
+$3.66M
2
ASPN icon
Aspen Aerogels
ASPN
+$2.95M
3
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$2.56M
4
EOLS icon
Evolus
EOLS
+$1.72M
5
INDI icon
indie Semiconductor
INDI
+$1.37M

Sector Composition

Rank Sector Weight
1 Technology 18.52%
2 Healthcare 17.49%
3 Financials 5.11%
4 Real Estate 2.52%
5 Industrials 2.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMAX icon
151
PUT
IMAX
IMAX
$2.8B
$2.3K ﹤0.01%
14,900
-5,100
-26% -$87.8K
GSK icon
152
PUT
GSK
GSK
$103B
$1.91K ﹤0.01%
25,500
-26,800
-51% -$938K
BCS icon
153
PUT
Barclays
BCS
$93.8B
$1.6K ﹤0.01%
16,000
-6,100
-28% -$50.4K
XNTK icon
154
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.11B
$1.55K ﹤0.01%
+12,900
New +$1.44M
ACRS icon
155
CALL
Aclaris Therapeutics
ACRS
$772M
$1.28K ﹤0.01%
+25,600
New +$325K
BMY icon
156
PUT
Bristol-Myers Squibb
BMY
$134B
$1.28K ﹤0.01%
+12,800
New +$903K
ISEE
157
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$643 ﹤0.01%
25,700
+200
+0.8% +$4.38K
ASPN icon
158
Aspen Aerogels
ASPN
$392M
– –
-250,250
Closed -$2.95M
ATEC icon
159
Alphatec Holdings
ATEC
$1.56B
– –
-4,000
Closed -$49.4K
AXSM icon
160
CALL
Axsome Therapeutics
AXSM
$10.9B
– –
-25,500
Closed -$16.7K
AXSM icon
161
PUT
Axsome Therapeutics
AXSM
$10.9B
– –
-26,200
Closed -$11K
BKNG icon
162
Booking.com
BKNG
$149B
– –
-8,950
Closed -$721K
BNTX icon
163
BioNTech
BNTX
$23.3B
– –
-3,200
Closed -$481K
CIO
164
DELISTED
City Office REIT
CIO
– –
-16,050
Closed -$134K
CNTX icon
165
Context Therapeutics
CNTX
$55.5M
– –
-281,889
Closed -$186K
COHR icon
166
Coherent
COHR
$56.4B
– –
-25,600
Closed -$899K
EOLS icon
167
Evolus
EOLS
$398M
– –
-228,580
Closed -$1.72M
ESS icon
168
Essex Property Trust
ESS
$18.4B
– –
-635
Closed -$135K
EXEL icon
169
CALL
Exelixis
EXEL
$13.8B
– –
-51,100
Closed -$14.1K
EXEL icon
170
PUT
Exelixis
EXEL
$13.8B
– –
-13,400
Closed -$5.03K
HASI icon
171
PUT
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.93B
– –
-14,900
Closed -$11.5K
INCY icon
172
CALL
Incyte
INCY
$24B
– –
-44,800
Closed -$13.9K
INCY icon
173
Incyte
INCY
$24B
– –
-12,800
Closed -$1.03M
INCY icon
174
PUT
Incyte
INCY
$24B
– –
-12,800
Closed -$8.32K
IRT icon
175
Independence Realty Trust
IRT
$3.95B
– –
-15,839
Closed -$267K
4 5 6
7
8

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q1 2023 Portfolio in Review

As of Q1 2023, Worth Venture Partners held 227 positions worth $205M, up 21% from $169M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Worth Venture Partners withdrew a net $35.2M in Q1 2023, closing 39 positions and reducing 41 holdings. Its most notable exit was Aspen Aerogels, an estimated $2.95M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Worth Venture Partners opened a new position in Marinus Pharmaceuticals, Inc worth $2.27M.

  • Worth Venture Partners's largest Q1 2023 buy was Marinus Pharmaceuticals, Inc: 328,735 shares worth $2.27M.
  • Worth Venture Partners added most to Digital Turbine in Q1 2023, an estimated $1.87M increase.
  • Worth Venture Partners's biggest Q1 2023 reduction was DZS Inc. Common Stock, cutting an estimated $3.66M.
  • Worth Venture Partners fully exited Aspen Aerogels in Q1 2023, selling an estimated $2.95M.
  • Worth Venture Partners's ten largest holdings make up 39% of its $205M portfolio in Q1 2023.
  • Worth Venture Partners opened 51 new positions and closed 39 in Q1 2023.
  • Worth Venture Partners's portfolio value rose 21% quarter-over-quarter to $205M.

Based on Worth Venture Partners's 13F filing for Q1 2023, filed 15 May 2023.